mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say https:// arstechnica.com/health/2026/08 /mrna-cancer-vaccine-succeeded-in-phase-3-melanoma-trial-moderna-and-merck-say/

mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say https:// arstechnica.com/health/2026/08 /mrna-cancer-vaccine-succeeded-in-phase-3-melanoma-trial-moderna-and-merck-say/

1 social postother

Claim audit

No BS check run yet — press ⚖ to extract this story's claims and verify them against independent sources.

All coverage